Anemia Management in the Era of Triple Combination Therapy for Chronic HCV

Boceprevir or telaprevir plus ribavirin (RBV) and pegylated interferon-α (pegIFN-α) is the new standard-of-care therapy for patients who are chronically infected with genotype 1 hepatitis C virus (HCV). The addition of these protease inhibitors to the RBV/pegIFN-α combination regimen has significant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jacobson, Ira M., Kowdley, Kris V., Kwo, Paul Y.
Format: Artigo
Jezik:Inglês
Izdano: Millennium Medical Publishing 2012
Teme:
CMExpress Opportunity
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533206/
https://ncbi.nlm.nih.gov/pubmed/23293572
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki